Quintiles

INC Research launches its IPO

Monday, November 10, 2014 02:38 PM

Global CRO INC Research launched its initial public offering today, raising $150 million by selling just over 8.1 million shares at $18.50 per share—the middle of the expected $17-$20 range. The stock climbed 9% in early trading past $20.75 before settling to $20 by late afternoon.

More... »

Quest Diagnostics

RxTrials names Adam Chasse president

Wednesday, October 8, 2014 01:33 PM

Ellicott City, Md.-based RxTrials, an investigative site network and consulting firm, has appointed Adam Chasse president.

More... »


New ACRO survey: CRO members saw big growth in past decade

Friday, September 19, 2014 03:34 PM

The biopharmaceutical industry’s outsourcing strategy has enabled the eight members of the Association of Clinical Research Organizations (ACRO) to double in size over the past 10 years, today employing more than 100,000 professionals worldwide with a global payroll of nearly $6 billion.

More... »

Quintiles launches new customer solution

Monday, September 15, 2014 12:21 PM

Global CRO Quintiles has launched the Quintiles Emerging Biopharma Solution, a new offering designed to meet the unique clinical development needs and goals of emerging biopharmaceutical companies in the global marketplace.

More... »

Expression Analysis, Illumina launch 2014 grant program

Monday, August 25, 2014 02:13 PM

Expression Analysis (EA), a Quintiles company based in Research Triangle Park, N.C., is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research.

More... »

Ventana, Quintiles ink agreement for companion diagnostic services in China

Thursday, August 7, 2014 10:00 AM

Ventana Medical Systems, a member of the Roche Group, has inked a new agreement with Quintiles to offer College of American Pathology (CAP) standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. China is one of the only countries in the world that requires all patient samples be tested in China, even those used in clinical trials.

More... »

HeartWare International appoints Katrin Leadley chief medical officer

Monday, August 4, 2014 03:48 PM

HeartWare International, an innovator of less invasive, miniaturized circulatory support technologies for advanced heart failure, has appointed Katrin Leadley, M.D., as chief medical officer of HeartWare, effective September 1. Leadley brings to HeartWare extensive strategic leadership, with more than 20 years of clinical and industry experience at life sciences firms, including QuintilesBoston Scientific and JenaValve Technology in Munich, where she spent the last three years as chief medical officer leading the company's clinical, regulatory, scientific and medical activities.

More... »

Quintiles, Modern Marketing Concepts launch marketing analytics platform

Monday, June 23, 2014 03:46 PM

Quintiles and Modern Marketing Concepts (MMC) have launched a new marketing analytics platform that enables Quintiles to optimize sales and marketing efforts on behalf of its U.S. commercialization customers. Quintiles and MMC combine proprietary channel preference data with the innovative Next Action Marketing platform to create optimized physician communication strategies that align with their preferences and behaviors.

More... »

DrugDev establishes DrugDev Innovation Lab, partners with two technology firms

Thursday, June 12, 2014 01:43 PM

DrugDev, a provider of technology-driven solutions that help investigators, sponsors and CROs conduct more trials together, has established the DrugDev Innovation Lab, a technology incubator designed to accelerate emerging solutions in clinical trial automation.

More... »

Quintiles, American Physical Therapy Association develop outcomes registry

Wednesday, June 11, 2014 12:52 PM

Quintiles and the American Physical Therapy Association (APTA) have formed a new strategic collaboration to develop and implement the Physical Therapy Outcomes Registry, intended to be the largest and most comprehensive physical therapy electronic repository to date.

More... »


CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs